HOME >> BIOLOGY >> NEWS
New 'mighty mice' research brings muscle growth closer to reality

The Johns Hopkins scientists who first created "mighty mice" by genetically engineering animals with a missing growth regulator called myostatin have now created a second group of mice whose genetic makeup shows it's possible to get the same effect by blocking the gene for myostatin, rather than entirely knocking it out.

Reporting in the July 16 issue of the Proceedings of the National Academy of Sciences, the researchers say they have identified several proteins (follastatin, mutant activin type II receptors, and myostatin propetide) that can block the activity of myostatin. Moreover, they have engineered mice with normal myostatin, but various levels of these blockers.

"By expressing high levels of these proteins in mice, we have been able to increase muscle mass to levels comparable to those seen in mice completely lacking myostatin," says Se-Jin Lee, M.D., Ph.D., lead author of the Hopkins study. "Although more study is needed to prove that these mice are good models for humans and to find other myostatin signaling components, our work suggests that these kinds of myostatin antagonists may be effective muscle-enhancing agents for both human and agricultural applications."

The 1997 report from Lee and his colleagues focused on the muscle-building capability of knocking out, or deleting the myostatin gene, to allow the buildup of skeletal muscle in the animals.

"Until now, it's been purely theoretical that we could block the gene and obtain the same muscle-building effect as deleting the gene," Lee continues.

The researchers discovered that while mice that were engineered to produce large amounts of follistatin exhibited the most herculean muscles, the other two groups, one with excess mutant activin II receptors and one with myostatin peptide, also showed increased muscle growth.

Scientists are hopeful that the finding will provide new opportunities to treat many muscle-wasting diseases like muscular dystroph
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
16-Jul-2001


Page: 1 2

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
3. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Award winning researchers reveal potential new role for Glivec
6. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
7. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
8. Gene chips research in cotton could lead to superior variety
9. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
10. New hydrothermal vents discovered as South Pacific Odyssey research begins
11. University of Alberta researcher looks for clues to mysterious disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... August 01, 2019 , ... USDM Life Sciences (USDM) ... , will deliver a detailed webinar addressing challenges with the upcoming EU MDR ... of UDI and has held a variety of positions over his 26 years at ...
(Date:7/24/2019)... , ... July 24, 2019 , ... ... Donna Hartzfeld, PhD, a quality assurance expert with more than 20 years of ... and combination products, has joined the firm as an Expert Consultant. , Dr. ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... bioactive glass synthetic biologic strip indicated for spine and orthopedic use. Bioactive glass ... bone. Bioactive glass has been clinically-proven in orthopedics for over 30 years and ...
Breaking Biology News(10 mins):
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ., a ... announced today that they will be receiving 3 awards at the 2019 CRO Leadership ... 2 awards in the categories of overall Quality and Compatibility (Access to desired markets, ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... USPTO providing proprietary interest to our methodology, processes, and diagnostic techniques. The ... TREATMENT… extends Somnology’s IP rights including our proprietary sleep scoring methodology. The ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally ... acquisition provides Object exclusive ownership and commercialization rights to a full spectrum of ...
(Date:5/22/2019)... ... May 22, 2019 , ... Artemis (formerly ... $8 million Series A funding round co-led by Astanor Ventures and ... Development Fund and iSelect Fund . The company has raised $11.75m to ...
Breaking Biology Technology:
Cached News: